Log In
Print
BCIQ
Print
Print this Print this
 

mGluR2 NAM

  Manage Alerts
Collapse Summary General Information
Company Domain Therapeutics S.A.
DescriptionNegative allosteric modulator of metabotropic glutamate receptor subtype 2 (mGluR2)
Molecular Target Metabotropic glutamate receptor subtype 2 (mGluR2) (GRM2)
Mechanism of ActionMetabotropic glutamate receptor subtype 2 (mGluR2) antagonist
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today